These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3876901)

  • 21. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

  • 22. Raynaud's phenomenon. A practical approach to a common problem.
    Needs J; Laurent R; Manolios N
    Aust Fam Physician; 1993 Jun; 22(6):1049, 1052-8, 1062-5. PubMed ID: 8338452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic (im)possibilities in Raynaud's phenomenon].
    Jager J
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1044. PubMed ID: 8684503
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.
    Rugienė R; Dadonienė J; Aleknavičius E; Tikuišis R; Distler J; Schett G; Venalis P; Venalis A
    Clin Rheumatol; 2011 Mar; 30(3):373-80. PubMed ID: 21225302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of primary and secondary Raynaud's disease by carotid arterial stiffness.
    Cheng KS; Tiwari A; Boutin A; Denton CP; Black CM; Morris R; Seifalian AM; Hamilton G
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):336-41. PubMed ID: 12651172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon].
    Laroche GP; Thériault G
    Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Raynaud's phenomenon].
    Piérard-Franchimont C; Piérard GE; Hermanns-Lê T
    Rev Med Liege; 2012 Dec; 67(12):655-9. PubMed ID: 23342877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon.
    Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL
    Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes.
    Harel L; Straussberg R; Rudich H; Cohen AH; Amir J
    Clin Infect Dis; 2000 Mar; 30(3):500-3. PubMed ID: 10722434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
    Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
    Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The specificity of capillaroscopic pattern in connective autoimmune diseases. A comparison with microvascular changes in diseases of social importance: arterial hypertension and diabetes mellitus.
    Lambova SN; Müller-Ladner U
    Mod Rheumatol; 2009; 19(6):600-5. PubMed ID: 19779765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The natural course of Raynaud's phenomenon].
    Clavijo F; Krahenbuhl B
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease.
    Weihrauch TR; Korting GW
    Br J Dermatol; 1982 Sep; 107(3):325-32. PubMed ID: 7115611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Minimal etiological evaluation of Raynaud's phenomenon. 102 cases].
    Priollet P; Yeni P; Vayssairat M; Segond P; Tallon F; Housset E
    Presse Med; 1985 Nov; 14(39):1999-2003. PubMed ID: 2933722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.